Osteopenia Completed Phase 3 Trials for Raloxifene (DB00481)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT003105313-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal WomenPrevention